Multisystem inflammatory syndrome in European White children – study of 274 cases

Background Despite the growing literature on multisystem inﬂammatory syndrome in children (MIS-C), the data in European White population is limited. Our aim was to capture MIS-C emergence in Poland (central Europe) and to describe its characteristics with a focus on severity determinants.


Introduction
2][3][4][5][6][7][8][9] Despite similarities to other inflammatory conditions, e.g.Kawasaki disease (KD), macrophage activation syndrome (MAS), or toxic shock syndrome, MIS-C has its distinct features. 8,9MIS-C is characterised by a sudden onset of rapidly progressing multisystem inflammation which particularly affects the cardiovascular system, resulting in cardiac dysfunction and shock.][6][7][8][9] In order to perceive the emergence of MIS-C in our country, we have launched a national surveillance of inflammatory disorders in children (MultiOrgan Inflammatory Syndromes COVID-19 Related Study, MOIS-CoR).Following COVID-19 second wave in Autumn 2020, a rise in MIS-C prevalence has emerged in Poland.Here we report the results of the survey, revealing a consistent picture of MIS-C in our population, yet with some unique local characteristics.

Data sources
The surveillance was launched on 25th May 2020.The inclusion criteria are presented in Appendix (p 2).Ethical approval was obtained from the Bioethics Committee at Wroclaw Medical University (CWN UMW BW: 313/2020).Waiver of informed consent was obtained with only deidentified data transmitted and analysed.
Children aged 0-18 years old with inflammatory conditions were voluntarily reported from 42 cities from all over the country (appendix p 8). Anonymised patients' data were retrospectively and prospectively extracted from health records and collected through an online questionnaire developed for that purpose.Demographic data, clinical characteristics, laboratory parameters, cardiovascular evaluation results, treatment and outcome data were collected.Vital signs and laboratory parameters were obtained at admission and at their respective peaks.Here we report the data covering period between 4th March 2020 (when the first COVID-19 case was confirmed in Poland) and 20th February 2021.The analysis was data-driven.Nine of the presented cases were included in our previous cursory report. 10

MIS-C Case Definition
For the sake of this study, we adopted World Health Organization (WHO) MIS-C case definition 3 , as follows: • children 0-18 years old with fever lasting at least three days

Echocardiographic Abnormalities
Echocardiography results were categorised based on descriptive results and left ventricular ejection fraction (EF) and coronary artery measurements whenever available.Heart dysfunction was defined as EF <55% and severe heart dysfunction as EF <35%.Coronary artery Z-score was calculated using Dallaire equation or Boston Children's Hospital Z-score calculator, depending on the body surface area.Dilation was defined by Z-score between 2 to 2.5, while aneurysm by Z-score ≥2.5. 11The worst available EF and the largest coronary Z-scores were included.The echography results were assessed by two independent cardiologists.

Clinical Definitions
Diagnostic criteria of KD in its typical and atypical (aKD) form were adapted from American Heart Association (AHA) guidelines. 11MAS was diagnosed based on Paediatric Rheumatology International Trials Organization criteria (consult appendix p 2). 12 The level of consciousness was evaluated using the AVPU scale.
Nutritional status was assessed using the body-mass index (BMI), converted into Z-scores based on the WHO reference standards for children younger than 5 years 13 and national reference standards for older children. 14

Statistical Methods
We describe variables in relation to the sum of cases for which the variable was recorded.We assumed missing values to be distributed randomly and independently from the data, and propagated them through aforementioned clinical definitions according to Łukasiewicz logic.Fulfilment of all aforementioned study definitions was automatically evaluated by a dedicated software. For

Study Group
As of 20th February 2021, 399 children have been registered to the surveillance, 342 of whom fulfilled the inclusion criteria and 274 fulfilled MIS-C diagnostic criteria (Figure 1

Clinical Presentation
The median time between first symptoms and hospital admission was five days, and the median fever length was seven days.The vital signs at admission and at their respective peaks are presented in

Laboratory Results
Laboratory parameters at admission and at respective peaks are summarised in

Sex-dependent Clinical and Laboratory Characteristics
Male patients were diagnosed with MIS-C more often than expected from demographic structure, but only in the older age bracket (Figure 2).We have identified some characteristics which corresponded with this discrepancy (Figure 3, see also

Treatment and Outcome
Treatment is presented in Table

Discussion
In this study we have described the largest published so far cohort of European White children with confirmed MIS-C.Despite being initially reported as Kawasaki-like disease, MIS-C appeared to be a distinct entity soon after. 8,9hildren in our cohort fulfilled KD/aKD diagnostic criteria more frequently than in other reports, but they concomitantly presented with unique features typical for MIS-C.On the other hand, in contrast to Western European and the United States (US) reports, the severity of the disease appeared substantially milder, as expressed by only 8.4% of patients hospitalised in PICU and two deaths.]8,9 These discrepancies might be related to more homogenous genetic and racial characteristics of the Polish population.]8,9 Importantly, the proportion of Black and Hispanic ethnicity in MIS-C groups was significantly higher than in local societies. 7,15It is not clear whether this overrepresentation of ethnic minorities and underrepresentation of non-Hispanic White children among MIS-C patients reflect genetic predisposition or higher exposure to SARS-CoV-2, as COVID-19 disproportionately affected Hispanic and Black subpopulations. 15,16o hundred seventy-four MIS-C cases captured in Poland with a 7.31 million children population as compared to 2060 cases reported in the USA with 74 million children at the same time, 1,17 suggest that MIS-C prevalence in our country could have reached a level comparable to the US, despite specific, homogenous racial background.
Another issue is whether race/ethnicity is associated with the severity of the disease.Some authors suggest that children of Black ethnicity present a more severe clinical course of MIS-C, 4,6 whereas others 18 argue against it.Our cohort was almost exclusively composed of European White children which is a major demographic characteristic distinguishing it from other MIS-C cohorts.This should be considered as a possible explanation of milder clinical presentation with favourable outcome, however, this conclusion should be treated with caution and requires further analysis.
Another feature of our cohort was the relatively small proportion of obese children as compared to majority of reports from other countries (6.7% vs. 18-26%). 4,6,9This could have possibly resulted from lower obesity prevalence among children in Poland (up to 13%). 19Interestingly, in the US, obesity is more prevalent in Black (up to 22%) and Hispanic (up to 26%) children as opposed to non-Hispanic White (up to 14.1%). 20It is unknown whether obesity is a risk factor for developing MIS-C nor if it is connected to its severity.In our study, we found no association between BMI Z-score or obesity and severity of the disease.
Polish recommendations for MIS-C treatment are similar to those from the USA or the United Kingdom. 21,22Treatment used in our cohort did not differ substantially from treatment reported by other authors -most children received IVIG and a large proportion also got steroids.]8,9 Moreover, the median day of hospital admission since the first symptoms was similar to other reports. 6,23ence, the therapeutic approach is an unlikely factor of a more favourable outcome in Polish children with MIS-C.
Despite relatively uniform clinical presentation in terms of mucocutaneous, gastrointestinal, or respiratory manifestations across the age groups, cardiovascular involvement significantly increased with age, which is in line with Dufort and Abrams findings. 4,23Laboratory markers of the heart injury were elevated in the majority of patients, whereas hypotension was present in 40.7% and decreased EF -in 22.6% of patients.
Cardiac involvement is a major factor determining MIS-C severity, however data about cardiovascular complications are inconsistent.This is partially due to varying (sometimes unspecified) definitions used by different authors, 4,6,23,24 and varying inclusion criteria -either broader than WHO MIS-C case definition, 24 or narrowed only to the most severe cases. 76][7][8]24 Our findings place Polish children with MIS-C within the "milder end" of the acute cardiovascular complications spectrum described above.
Similarly, the prevalence of coronary artery involvement in MIS-C is debatable.Undoubtedly aneurysms may complicate the disease, cases of giant aneurysms have been described, 24 but the true prevalence of aneurysms is unknown.CAA prevalence may be overestimated, as coronary dilation may be a result of an acute febrile condition or myocarditis. 2524 Interestingly, we have observed that some MIS-C features differed between girls and boys in adolescence and, to our knowledge, this is the first report of sex-related discrepancies in MIS-C presentation.Teenage boys had more frequent cardiac involvement, MAS and PICU hospitalization rate.The more severe course of COVID-19 in adult males is well established. 26While some authors postulate that it is linked with genetic and immunological background, 27 others suggest that sex hormones may play a role. 28,29COVID-19 and MIS-C are separate entities, but share some similarities being hyperinflammatory conditions.In our cohort, the distinction between children of different sex appeared at pubertal age, which might support the hormonal theory.
Finally, we aimed to identify clinical and laboratory features specific to patients who required intensive care.Similarly to previous reports, the only demographic characteristic associated with PICU admission was older age. 4,6The median time of hospital admission since the first symptoms did not differ significantly for PICU patients.They could be distinguished by their vital signs at hospital admission: decreased level of consciousness, longer CRT, higher respiratory rate and lower sBP.In concordance with other reports, the severity of disease was correlated with the particularly high inflammatory markers. 6,8The involvement of the laboratory evaluation at admission is one of strengths of our study; we found that initial values of inflammatory markers, D-dimers, albumin, eGFR, and markers of the heart injury correlated with the progression to severe disease.

Limitations
The study relied on voluntary participation, hence a number of MIS-C cases might have been missed or biased by non-random sampling.Some patients meeting the MIS-C criteria may have been misclassified, e.g.due to unequal access to SARS-CoV-2 testing or missing data.Whenever possible, outliers in our data were verified at source.We have not obtained the data about catecholamine treatment.The broad MIS-C case definition and advanced epidemiological situation allowed children with alternative diagnoses and coincidental positive SARS-CoV-2 results to be included in our cohort.

Figure 1 .
Figure 1.Eligibility Flowchart of patients reported in MultiOrgan Inflammatory Syndromes COVID-19 Related Study (MOIS-CoR) and temporal distribution of MIS-C cases in Poland A) Eligibility Flowchart of patients reported in MultiOrgan Inflammatory Syndromes COVID-19 Related Study (MOIS-CoR), 4th March 2020 to 20th February 2021 Abbreviations: MIS-C, multisystem inflammatory syndrome in children; MOIS-CoR, MultiOrgan Inflammatory Syndromes COVID-19 Related Study; RT-PCR, real-time transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 a Study inclusion criteria are presented STable 1. b MIS-C criteria were based on the World Health Organization definition, precise criteria are presented in Materials and Methods section.c Anamnesis encompassed history of previous confirmed SARS-CoV-2 infection or contact with a proven coronavirus disease 2019 (COVID-19) B) Temporal distribution of MIS-C cases in Poland, 4th March 2020 to 20th February 2021 Bars indicate daily number of cases and line indicates weekly average number of cases

Figure 2 .Figure 3 .
Figure 2. Incidence of reported MIS-C cases within the Polish population of children aged 0-18 years, according to age and sex Abbreviations: MIS-C, multisystem inflammatory syndrome in children

Table 1 and
Table 2 for sex-adjusted p-value).

Table 1 .
Demographic and clinical characteristics, management and outcome of MIS-C cohort

Table 2 . Vital signs and laboratory results of MIS-C cohort at admission and at respective peaks
AlAT, alanine transaminase; AVPU, AVPU scale; BNP, brain natriuretic peptide; eGFR, estimated glomerular filtration rate; IQR, interquartile range; med, median; MIS-C, multisystem inflammatory syndrome in children; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; PICU, paediatric intensive care unit * lowest values were obtained ** highest values were obtained a Troponin >50 ng/L b BNP/NT-proBNP >150 ng/mL